References
- Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., … Taylor, D. (2010). Effectiveness and safety of Tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science, 329, 1168–1174. doi:10.1126/science.1193748
- Antiretroviral Pregnancy Registry Steering Committee. (2012). Antiretroviral Pregnancy Register International Interim Report for 1 January 1989 to 31 January 2012. Wilmington, NC: Registry Coordinating Center. Retrieved from http://www.APRegistry.com
- Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wanqisi, J. … Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. The New England Journal of Medicine, 367, 399–410. doi:10.1056/NEJMoa1108524
- Castilla, J., Del Romero, J., Hernando, V., Marincovich, B., Garcia, S., & Rodriguez, C. (2005). Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. Journal of Acquired Immune Deficiency Syndrome, 40, 96–101. doi:10.1097/01.qai.0000157389.78374.45
- Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine, 365, 493–505. doi:10.1056/NEJMoa1105243
- Del Romero, J., Castilla, J., Hernando, V., Rodriguez, C., & Garcia, S. (2010). Combined antiretroviral treatment and heterosexual transmission of HIV-1: Cross sectional and prospective cohort study. British Medical Journal, 340, c2205. doi:10.1136/bmj.c2205
- Grant, R. M., Lama, J. R, Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. The New England Journal of Medicine, 63, 2587–2599. doi:10.1056/NEJMoa1011205
- Hendrix, C., Minnis, A., Guddera, V., Riddler, S., Salata, R., Nakabiito, C., … Richardson, B. (2011). MTN-001: A Phase 2 cross-over study of daily oral and vaginal TFV in healthy, sexually active women results in significantly different product acceptability and vaginal tissue drug concentrations. Oral presented at the Eighteenth Conference on Retroviruses and Opportunistic Infections, Boston. Retrieved from http://www.retroconference.org/2011/Abstracts/42418.htm
- Melo, M. G., Santos, B. R., De Cassia Lira, R., Varella, I. S., Turella, M. L., Rocha, T. M., … Nielsen-Saines, K. (2008). Sexual transmission of HIV-1 among serodiscordant couples in Porto Alegre, southern Brazil. Sexually Transmitted Diseases, 35, 912–5. doi:10.1097/OLQ.0b013e31817e2491
- Mugo, N., Celum, C., Donnell, D., Farquhar, C., Fife, K., Ronald, A., … Baeten, J. (2012). Pregnancy incidence and birth outcomes among in a clinical trial of PrEP: Uganda and Kenya. Poster presented at the 19th Conference on Retroviruses and Opportunistic Infections. Seattle, WA. Retrieved from http://www.retroconference.org/2012b/Abstracts/43083.htm
- Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., … Gray, R. H. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. The New England Journal of Medicine, 342, 921–929. doi:10.1056/NEJM200003303421303
- Semprini, A. E., Levi-Setti, P., Bozzo, M., Ravizza, M., Taglioretti, A., Sulpizio, P., … Pardi, G. (1992). Insemination of HIV-negative women with processed semen of HIV-positive partners. The Lancet, 340, 1317–1319. doi:10.1016/0140-6736(92)92495-2
- Squires, K., Olmscheid, B., Guyer, B., & Zhang, S. (2009). Tenofovir-DF (TDF)-containing antiretroviral (ARV) regimens for treatment of HIV in pregnancy: Findings from the Antiretroviral Pregnancy Registry. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco. Retrieved from http://www.hivandhepatitis.com/2009icr/icaac/pdfs/1_SquiresTDF.pdf
- Taylor, S., & Davies, S. (2010). Antiretroviral drug concentrations in the male and female genital tract: Implications for the sexual transmission of HIV. Current Opinion in HIV and AIDS, 5, 335–343. doi:10.1097/COH.0b013e32833a0b69
- Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., … Brooks, J. T. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. The New England Journal of Medicine, 367, 423–434. doi:10.1056/NEJMoa1110711
- Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., … Taylor, D. (2012). Preexposure prophylaxis for HIV infection among African women. The New England Journal of Medicine, 367, 411–422. doi:10.1056/NEJMoa1202614
- Vernazza, P., Brenner, I., & Graf, I. (2007). Pre-exposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child. Poster discussion at the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention: Abstract MOPDC01. Retrieved from http://www.iasociety.org/Default.aspx?pageId=11&abstractId=200703139
- Vernazza, P., Hirschel, B., Bernasconi, E., & Flepp, M. (2008). HIV-positive individuals without additional sexually transmitted diseases (STD) and on effective anti-retroviral therapy are sexually non-infectious. Bulletin des Médecins Suisses, 89, 5.
- Vernazza, P., Graf, I., Sonnenberg-Schwan, U., Geit, M., & MeurerA. (2011). Preexposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child. AIDS, 25, 2005–2008. doi:10.1097/QAD.0b013e32834a36d0
![Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.]({"type":"image" , "src" : "/sda/112443/Skyscraper-socialsciences.png"})